Insights into COVID-19 Chemotherapies: Potential and Challenges

Abstract

The coronavirus disease 2019 (COVID-19), a newly emerged infectious disease caused by SARS-CoV-2 virus, has recently become pandemic. Although several therapeutic options are currently available for the treatment of COVID-19, no effective antiviral agents have been developed yet. Many countries follow the strategy of keeping the patient in good state and count on his own immune system to develop an effective immune response. Since the beginning of the pandemic, many previous therapeutic options have been used in COVID-19 treatment including antiviral, non-antiviral drugs and convalescent plasma-based therapies. This review delivers comprehensive illustration of the current therapeutic drugs that have been used for COVID-19 treatment all over the world since the pandemic starts.